adtralza
leo pharma a/s - tralokinumab - dermatitis, atopisk - andre dermatologiske præparater - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
engerix-b 20 mikrogram/1 ml 20 mikrogram/ml injektionsvæske, suspension, fyldt injektionssprøjte
paranova danmark a/s - hepatitis b virus overfladeantigen (rdna) - injektionsvæske, suspension, fyldt injektionssprøjte - 20 mikrogram/ml
ebglyss
almirall, s.a. - lebrikizumab - dermatitis, atopisk - andre dermatologiske præparater - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.
erythromycin "panpharma" 500 mg pulver til infusionsvæske, opløsning
panpharma - erythromycinlactobionat - pulver til infusionsvæske, opløsning - 500 mg